Spineart is proud to announce the launch of its upgraded, and now single-use, TEKTONA®2 Vertebral Fracture Reduction System, featuring enhanced ergonomics and usability.
Aligned with the company’s goal of transforming spine surgery for patients, surgeons, and hospitals; Spineart has developed a minimally invasive technology that enables a targeted, controlled, and multidirectional reduction of the vertebral compression fracture with a fully repositionable instrument.
Combined with TEKTONA® HV Cement, TEKTONA®2 preserves the trabecular structure, while enabling a precise and efficient treatment of the fracture.
To learn more about this differentiated technology, please visit (link to product page).
TEKTONA®2 is not FDA Approved.
More information here
Spineart is proud to announce the full launch of PERLA® Occipital fixation system, creating a complete OCT solution.
Built on 6 years of experience with the PERLA® system and a successful limited release period, the PERLA® OCT system is now ready to go worldwide.
Aligned with our goal of transforming spine surgery for patients, surgeons and hospitals, the PERLA® OCT system combines comprehensive, sterile packaged implant with intuitive instrument designs.
Designed with a commitment to Quality Innovation and Simplicity, the occipital implants offer:
· Occipital plates: three sizes with translating and rotating rod connections for increased versatility in rod alignment
· Occipital rods: Ti and CoCr rods in three pre-bent angles and an adjustable rod for precise and simplified angulation adjustments
· Occipital screws: self-tapping screws with streamlined, blunt tip for efficient and safe insertion
More information on : https://www.spineart.com/products/
We would like to thank our faculties, Dr. Abdollah Yassine Moufid, Dr. Cecile Swennen, Dr. Simon Teyssedou and Dr. Tanguy Vendeuvre, for their expertise and guidance during the two-day Academy held in Poitiers, France on April 13th-14th.
All participants had the opportunity to practice on re-vascularized anatomical specimens, share tips and tricks on a variety of techniques and discuss cases during interactive sessions.
We warmly thank all the participants for sharing their valuable experiences, benefitting their peers and patients alike.
In Miami last week, deformity surgeons from Latin America, Spain and the USA had the invaluable opportunity to share their techniques and learn from their peers. Over the course of 2 days, 30 participants contributed their insights on osteotomies and derotation, as well as thoracic and sacroiliac fixation, both in the classroom and the anatomical lab at the Miami Anatomical Research Center (MARC) Institute.
We warmly thank the two Chairmen, Dr. Samuel Pantoja (Chile) and Dr. Gabriel Rositto (Argentina), as well as our Guest speaker, Dr. Rod J. Oskouian, MD, FAANS (USA), and the four Faculties, Prof. Raphael Marcon (Brazil), Dr. Juan Martin Valdivia (USA), Dr. Luis Esparragoza Cabrera (Spain) and Dr. Ricardo Restrepo (Columbia), for generously sharing their time and expertise and all the participants for giving their valuable experiences, benefitting their peers and patients alike.
Spineart is proud to announce that more than 50’000 Cervical Disc Prosthesis BAGUERA® C have been implanted globally.
Strong of excellent results at 5 years, BAGUERA® C stands out as top-notch artificial disc replacement device, elegantly engineered to ensure a safe and effective treatment option for patients. The 10 years clinical follow-up are expected to be released soon and an IDE clinical investigation is ongoing in the USA.
The BAGUERA® C Cervical Disc Prosthesis is an MRI safe spinal device. The endplates of the BAGUERA® C are anatomically shaped and their inner bearing surfaces are coated with a diamond-like material that features a low coefficient of friction. The load sharing design and the guided mobile nucleus are intended to prevent excessive constraints on the facet joints and the adjacent levels.
More information about BAGUERA® C on : https://www.spineart.com/products/
Spineart is proud to partner with Dr. Hyun Bae at the Spine Institute, Santa Monica, California as part of two clinical trials evaluating BAGUERA® C, a new cervical disc replacement option for patients with degenerative cervical disc disease.
The clinical trials are evaluating the BAGUERA® C cervical artificial disc, which is designed to help maintain the natural behavior and mobility of a functional cervical spine.
Unlike spinal disc fusion, a common surgical treatment option, the goal of cervical disc replacement is to help preserve motion of the cervical spine or spinal segment after surgery. This can provide patients with improved quality of life after treatment.
Click here if you want to find out if you are a candidate: https://www.spineart.com/us/ide-clinical-investigation/
Want to find a clinical study site near you or learn more information about the two studies? Go to https://www.spineart.com/us/ide-clinical-investigation/
Investigational device limited by United States law to investigational use in the United States.